91 related articles for article (PubMed ID: 3970557)
41. Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon.
Maluish AE; Ortaldo JR; Conlon JC; Sherwin SA; Leavitt R; Strong DM; Weirnik P; Oldham RK; Herberman RB
J Immunol; 1983 Jul; 131(1):503-7. PubMed ID: 6863923
[TBL] [Abstract][Full Text] [Related]
42. [Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].
Sakamoto M; Mikasa K; Hamada K; Konishi M; Maeda K; Yoshimoto E; Ueda K; Majima T; Sawaki M; Kita E; Narita N
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2259-66. PubMed ID: 9881083
[TBL] [Abstract][Full Text] [Related]
43. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
44. Anticoagulant drugs increase natural killer cell activity in lung cancer.
Bobek V; Boubelik M; Fiserová A; L'uptovcová M; Vannucci L; Kacprzak G; Kolodzej J; Majewski AM; Hoffman RM
Lung Cancer; 2005 Feb; 47(2):215-23. PubMed ID: 15639720
[TBL] [Abstract][Full Text] [Related]
45. Deficient natural killer cell activity in alcoholic cirrhosis.
Charpentier B; Franco D; Paci L; Charra M; Martin B; Vuitton D; Fries D
Clin Exp Immunol; 1984 Oct; 58(1):107-15. PubMed ID: 6236915
[TBL] [Abstract][Full Text] [Related]
46. [Long-term immunological study on postoperative adjuvant treatment with interferon-gamma in patients with renal cell carcinoma who underwent nephrectomy].
Miura H; Arai H; Matsuoka A; Yazawa K; Satoh E; Nishimura K; Honda M; Fujioka H
Hinyokika Kiyo; 1999 Feb; 45(2):79-83. PubMed ID: 10212778
[TBL] [Abstract][Full Text] [Related]
47. Parameters of interferon action: I. Immunological effects of whole cell leukocyte interferon (IFN-alpha) in phase I-II trials.
Ernstoff MS; Fusi S; Kirkwood JM
J Biol Response Mod; 1983; 2(6):528-39. PubMed ID: 6363630
[TBL] [Abstract][Full Text] [Related]
48. Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice.
Nokihara H; Yanagawa H; Nishioka Y; Yano S; Mukaida N; Matsushima K; Sone S
Cancer Res; 2000 Dec; 60(24):7002-7. PubMed ID: 11156403
[TBL] [Abstract][Full Text] [Related]
49. Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Berek JS; Hacker NF; Lichtenstein A; Jung T; Spina C; Knox RM; Brady J; Greene T; Ettinger LM; Lagasse LD
Cancer Res; 1985 Sep; 45(9):4447-53. PubMed ID: 4028027
[TBL] [Abstract][Full Text] [Related]
50. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
[TBL] [Abstract][Full Text] [Related]
52. [A multi-center trial of MY-1, a new biological response modifier, on the immunological parameters of postoperative gastric cancer patients].
Ochiai T; Sato H; Isono K; Uematsu T; Nakajima K; Mukai M; Asano T; Onoda S; Morioka Y; Danno M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):959-69. PubMed ID: 3963860
[TBL] [Abstract][Full Text] [Related]
53. [The count of the large granule-containing lymphocytes of the peripheral blood and the natural killer activity in patients with malignant tumors].
Kindzel'skiĭ LP; Zlochevskaia LL; Tsyganok TV; Shabaeva MM; Zhukova MM; Rudaia OI
Vrach Delo; 1990 Aug; (8):31-2. PubMed ID: 2256279
[TBL] [Abstract][Full Text] [Related]
54. [Effect of natural and recombinant interferons on the development of an antiviral state and on the activity of natural killers].
Kuznetsov VP; Avdeev GI; Viadro MM; Leĭkin IuD; Frolova IS
Dokl Akad Nauk SSSR; 1985; 284(6):1514-6. PubMed ID: 3002740
[No Abstract] [Full Text] [Related]
55. Antitumor effect of human recombinant interferon-beta against human melanomas transplanted into nude mice.
Gomi K; Morimoto M; Nakamizo N
J Pharmacobiodyn; 1984 Dec; 7(12):951-61. PubMed ID: 6533284
[TBL] [Abstract][Full Text] [Related]
56. Decreased natural killer cell activity after prolonged administration of interferon in cancer patients.
Bravo Cuellar A; Martin Ruiz JL; Orbach-Arbouys S
Immunol Lett; 1985; 10(3-4):137-9. PubMed ID: 4044011
[TBL] [Abstract][Full Text] [Related]
57. [Increase of the functional activity of natural killers under the effects of the pharmacological correction of the sympathoadrenal system state in patients with lung cancer].
Umanskiĭ VIu; Balitskaia EK; Shmal'ko IuP; Kas'ianenko IV
Vopr Onkol; 1990; 36(1):13-7. PubMed ID: 2305558
[TBL] [Abstract][Full Text] [Related]
58. Growth-inhibitory activity of recombinant human interferon-beta against cultured human cells.
Gomi K; Morimoto M; Nakamizo N
Gan; 1983 Oct; 74(5):737-42. PubMed ID: 6642144
[TBL] [Abstract][Full Text] [Related]
59. [Natural beta-interferon for local use in the treatment of metastatic pleural effusion caused by neoplasm of the breast].
Terzoli E; Izzo F; Lucatelli S; Ranuzzi M
G Ital Oncol; 1989; 9(2-3):53-7. PubMed ID: 2767729
[TBL] [Abstract][Full Text] [Related]
60. Studies on the use of mumps virus for treatment of human cancer.
Okuno Y; Asada T; Yamanishi K; Otsuka T; Takahashi M; Tanioka T; Aoyama H; Fukui O; Matsumoto K; Uemura F; Wada A
Biken J; 1978 Jun; 21(2):37-49. PubMed ID: 749908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
